In addition, the expression of the five signature cytokines is negatively correlated with tumor purity in breast cancer, especially for IL-17A, IL-21, and IL-26 (Figure 3), which indicates that these cytokines are mainly derived from immune cells such as Th17 cells rather than tumor cells. This evidence concerns the gene IL26 and breast carcinoma.